了解IgM结构和生物学,以设计新的抗体治疗方法
Johannes Buchner1, Roberto Sitia2, Hristo L Svilenov3
1Department Bioscience, Center for Protein Assemblies, School of Natural Sciences, Technical University of Munich, Ernst-Otto-Fischer-Strasse 8, 85748, Garching, Germany.
概括
免疫球蛋白M (IgM) 抗体由于其独特的结构和结合能力而具有治疗潜力. 尽管临床前数据充满希望,但生产和理解IgM生物学方面的挑战阻碍了成功的临床转化.
科学领域:
- 免疫学 免疫学 免疫学
- 生物化学 生化学
- 开发治疗性抗体 开发治疗性抗体
背景情况:
- 免疫球蛋白M (IgM) 是适应性免疫的关键组成部分,以其米/六米结构和高性结合而闻名.
- IgM激活补充和与特定受体 (FcμR,Fcα/μR,pIgR) 相互作用的能力表明了不同的效应器功能和生物分布.
- 尽管有几十年的兴趣,但目前还没有批准治疗IgM抗体,这凸显了潜在和临床应用之间的差距.
研究的目的:
- 审查IgM生物发生和结构的最新进展.
- 讨论IgM与IgG的治疗优势,包括高性,点聚类和受体相互作用.
- 总结治疗IgM生产和临床开发中的挑战和机遇.
主要方法:
- 关于IgM生物学,结构和功能的最新进展的文献综述.
- 分析临床前和临床数据,比较IgM和IgG的疗效.
- 检查IgM生产技术和净化方法.
主要成果:
- 抗体M具有独特的结构特征 (五聚体/六聚体,J链),使其具有高性和高效的补充激活.
- 与IgG相比,IgM在各种体外试验中表现优越.
- 尽管在临床前取得了成功,但IgM抗体在临床试验中面临着挑战.
结论:
- 由于其独特的生物特性和工程机遇,IgM具有显著的治疗潜力.
- 成功的临床转化IgM疗法需要克服生产中的挑战和更深入地了解IgM生物学.
- 对IgM复杂相互作用和优化生产策略的进一步研究对于未来的治疗开发至关重要.
相关概念视频
01:10Antibody Structure
58.1K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
58.1K
01:25Antibody Structure and Classes
658
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
658
01:31Hybridoma Technology
13.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.8K
01:36Humoral Immune Responses
70.4K
Overview
70.4K
01:26Antibody Actions
973
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
973
01:41Affinity and Avidity
35.7K
Overview
35.7K